Vyant Bio, Inc.
VYNT
OTC PK
| 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | 06/30/2022 | |
|---|---|---|---|---|---|
| Net Income | 63.73% | -5.19% | -22.99% | 40.34% | 36.65% |
| Total Depreciation and Amortization | -54.92% | -2.53% | 0.00% | -4.35% | -13.75% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -0.75% | -81.10% | 100.28% | -78.39% | -64.19% |
| Change in Net Operating Assets | 72.25% | -2,526.67% | -90.87% | 423.65% | -153.85% |
| Cash from Operations | 67.75% | -70.38% | -46.05% | 45.86% | -4.81% |
| Capital Expenditure | -- | -- | 96.36% | 25.38% | -1,003.33% |
| Sale of Property, Plant, and Equipment | -100.00% | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 100.00% | -103.34% | 99,000.00% | -113.33% | 200.00% |
| Cash from Investing | -100.00% | -98.53% | 1,672.51% | 16.61% | -401.67% |
| Total Debt Issued | -- | -- | -100.00% | -- | -- |
| Total Debt Repaid | -184.27% | -48.33% | -1.69% | -55.26% | -11.76% |
| Issuance of Common Stock | -100.00% | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 620.00% | 93.90% | -60.78% |
| Cash from Financing | -168.56% | 4,712.50% | -104.06% | 197.52% | -48.53% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 60.21% | -900.93% | 128.03% | 51.29% | -13.68% |